These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14427048)

  • 1. [Dynamic changes of liver lipid fractions following the administration of massive doses of salicylates].
    NIEDERLAND TR; KOVACS P; DZURIK R; HOSTYN L; MARKO P
    Cas Lek Cesk; 1960 Jan; 99():98-101. PubMed ID: 14427048
    [No Abstract]   [Full Text] [Related]  

  • 2. [CHANGES IN THE CONCENTRATION OF SOME LIPID FRACTIONS IN THE KIDNEY FOLLOWING CHRONIC AND CHRONIC-INTERMITTENT ADMINISTRATION OF SALICYLATES].
    NIEDERLAND TR; DZURIK R; KRAJCI LAZARY B
    Cas Lek Cesk; 1964 Apr; 103():393-5. PubMed ID: 14160297
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dynamic changes in some lipid fractions in the kidneys after prolonged administration of salicylates].
    NIEDERLAND TR; KOVACS P; DZURIK R; HOSTYN L
    Cas Lek Cesk; 1961 Jan; 100():85-8. PubMed ID: 13728913
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of salicylates and related compounds on carbohydrate metabolism and on adrenal ascorbic acid and cholesterol concentrations.
    FEENEY GC; CARLO PE; SMITH PK
    J Pharmacol Exp Ther; 1955 Jul; 114(3):299-305. PubMed ID: 13243241
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dynamic changes of 1-ascorbic acid and cholesterol in the adrenals after massive doses of salicylates].
    NIEDERLAND TR; GVOZDJAK J; BRIXOVA E
    Cas Lek Cesk; 1960 Apr; 99():497-500. PubMed ID: 14427047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the concentration of 1-ascorbic acid and cholesterol in the adrenal gland during the course of chronic and chronic intermittent administration of salicylates].
    NIEDERLAND TR; GVOZDJAK J; BRIXOVA E; BACHLEDOVA E
    Bratisl Lek Listy; 1961; 41():647-51. PubMed ID: 14479611
    [No Abstract]   [Full Text] [Related]  

  • 7. Some effects of salicylate on mitochondria from rat liver.
    JEFFREY SW; SMITH MJ
    Biochem J; 1959 Jul; 72(3):462-5. PubMed ID: 14407020
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Inhibition of hepatic gluconeogenesis by salicylate.
    Poser W; Rust A
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R76. PubMed ID: 4276629
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the concentration of glycogen fractions in the striated muscle and myocardium in chronic and chronic-intermittent adminstrations of salicylates].
    NIEDERLAND TR; GOVZDJAK J; DOBIS J
    Bratisl Lek Listy; 1961; 41():415-9. PubMed ID: 14479610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Data on the effects of therapeutic doses of salicylates on carbohydrate metabolism of rheumatoid arthritics].
    GASPARDY G; VIDA M; BANYAI B
    Z Rheumaforsch; 1961 Oct; 20():336-43. PubMed ID: 13897164
    [No Abstract]   [Full Text] [Related]  

  • 11. Salicylates and metabolism.
    SMITH MJ
    J Pharm Pharmacol; 1959 Dec; 11():705-20. PubMed ID: 13832098
    [No Abstract]   [Full Text] [Related]  

  • 12. Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1.
    Smith BK; Ford RJ; Desjardins EM; Green AE; Hughes MC; Houde VP; Day EA; Marcinko K; Crane JD; Mottillo EP; Perry CG; Kemp BE; Tarnopolsky MA; Steinberg GR
    Diabetes; 2016 Nov; 65(11):3352-3361. PubMed ID: 27554471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of liver lipids following administration of vitamin E in rats fed a high carbohydrate-low protein diet].
    GIACALONE O; LA COMMARE AF; BARDINO M
    Boll Soc Ital Biol Sper; 1960 May; 36():437-9. PubMed ID: 13827790
    [No Abstract]   [Full Text] [Related]  

  • 14. [CHANGES IN THE CONCENTRATION OF LIVER AND KIDNEY PROTEINS DURING THE CHRONIC AND CHRONIC-INTERMITTENT ADMINISTRATION OF SALICYLATES].
    NIEDERLAND TR; FEDORCAKOVA A; BRIXOVA E; BACHLEDOVA E
    Bratisl Lek Listy; 1963; 2():655-9. PubMed ID: 14122404
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of protamine sulfate on hepatic lipid metabolism in normal conditions and in hypercholesterolic steatosis].
    CAVAZZUTI F; ANGELI G; BARATTA PF
    Arch Sci Med (Torino); 1959 Jun; 107():584-99. PubMed ID: 13808601
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of hypnotic and sedative drugs on lipid content in liver].
    ROIZMAN IS
    Farmakol Toksikol; 1960; 23():432-6. PubMed ID: 13742874
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic doses of salicylates. Effect on adrenal cortical secretory activity in normal subjects.
    ULLOA A; GAUTNEY MC; HOLLEY HL; HILL SR
    Arch Intern Med; 1960 Jun; 105():914-20. PubMed ID: 13840300
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cobalt chloride on content of lipids and lipoproteins in serum and liver of rats.
    Kaliman PA; Shalamov RV; Zagaiko AL
    Biochemistry (Mosc); 1997 Jul; 62(7):725-31. PubMed ID: 9331964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of salicylates on ventilatory response to inhaled carbon dioxide in normal subjects.
    SAMET P; FIERER EM; BERNSTEIN WH
    J Appl Physiol; 1960 Sep; 15():826-8. PubMed ID: 13745906
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid pattern in serum, liver, and aorta of turkeys fed diets added with beta-aminopropionitrile and cholesterol.
    KOWALEWSKI K
    Arch Int Pharmacodyn Ther; 1960 Jun; 126():56-62. PubMed ID: 13853458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.